Skip to content

Public FDA record

Z-2173-2024: Sight OLO CBC Test Kit, Model/Catalog Number: TK1. A disposable cartridge and sample preparation tools fo

Recall record Z-2173-2024 for SIGHT DIAGNOSTICS LTD. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2173-2024
Company in FDA record
SIGHT DIAGNOSTICS LTD
FDA classification date
Jun 21, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

One Test Kit lot (TK1-10114) shows a positive bias in the platelet count due to bacterial contamination which can result in elevated counts with a bias of 7.5 k/ul. This results in the test kit lot performing outside of the device specification.

Source facts

Action
On May 15, 2024, URGENT Medical Device Recall letters were sent to customers. Following identification of the affected lot units, please take the following action: 1. Please discontinue use and quarantine any product from Lot 10114. 2. Return any unused units of test kit Lot 10114 to the company or discard them immediately according to standard practice. NOTE: For return of unused test kits please indicate so in the acknowledgement and receipt form and Customer Support will contact you with further instructions. 3. Review previously obtained test results conducted with the affected lot and identify populations at higher risk. Retest if necessary. NOTE: If you require assistance in identifying samples tested using the affected lot please indicate so in the acknowledgment and receipt form and we will be happy to provide you with any necessary information. 4. If you are a distributor, please share this notification with any customer to whom the product was shipped, or may have been shipped. 5. You are kindly requested to fill out the attached Acknowledgement and Receipt Form and return it to Sight as soon as possible, and in any case no later than 30 days from the date of this notification, via email, to notifications@sightdx.com. Please provide the form even if you no longer have any product in inventory so that we can verify that all affected product has been removed. 6. If you are required to notify your local authority please use this notification and notify Sight as soon as possible. We appreciate your time and apologize for any inconvenience this may have caused. Please do not hesitate to reach out with any questions or feedback to Customer Support via the following channels: US Customers OLOsupport@sightdx.com Callback service (voicemail) +1-833-SIGHTDX (7444839 ext. 3) Text +1 617 4105226 Partners (Distributors) support@sightdx.com Callback service (voicemail) +44 0203 093 0772 (ext. 2) Text +44 7449 063724 Customer Support is available Mon-Fri EST- 2:00AM-7:00
Initiated
2024-05-13
Root cause
Process control
Distribution
Worldwide - US Nationwide distribution in the states of AL, FL, MS, TX, WI and the countries of Canada, Israel, Slovenia, Trinidad & Tobago.
Recall number
Z-2173-2024
Recall status
Open, Classified
CDRH record ID
207976
FDA classified
2024-06-21
Recall event number
94678

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗